Please enable Javascript
Jacob Appelbaum, MD, PhD
Articles by Jacob Appelbaum, MD, PhD
Is ‘Inflamodulation’ What’s Missing From AML Immunotherapy?
Jerald Radich, MD
Acute Myeloid Leukemia
|
March 11, 2024
This editorial outlines treatments for relapsed AML, T-Cell activation, and more.
Read More